StockNews.com began coverage on shares of GlycoMimetics (NASDAQ:GLYC – Free Report) in a research report sent to investors on Wednesday. The brokerage issued a sell rating on the biotechnology company’s stock. Other analysts have also recently issued research reports about the company. Capital One Financial cut GlycoMimetics from an overweight rating to an equal weight […]
GlycoMimetics (NASDAQ:GLYC) Research Coverage Started at StockNews com
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
North American Morning Briefing: Stock Futures -2-
morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.
GlycoMimetics (NASDAQ:GLYC) Lowered to Equal Weight at Capital One Financial
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.